UKONS 2018 | Crucial role of the cancer nurse in managing patients on CAR T-cell therapy

Kathleen McDermott

The importance of ensuring cancer nurses receive the essential education needed to be able to effectively manage patients on new cellular therapies cannot be underestimated. From the UK Oncology Nursing Society (UKONS) 2018 Annual Conference, in Glasgow, UK, Kathleen McDermott, RN, BSN, OCN, BMTCN, of the Dana-Farber Cancer Institute, Boston, MA, discusses the crucial role of the cancer nurse in the treatment of patients receiving CAR T-cell therapy, highlighting the importance of nurse education in managing patients on these novel therapies, as well as their role in educating patients.

Share this video